Navigation Links
Advanced Health Media Further Expands Investment in Regulatory Compliance; Company Announces Ms. Susan Y. Leonard as Chief Compliance Officer
Date:9/22/2010

BRIDGEWATER, N.J., Sept. 22 /PRNewswire/ -- Today, Advanced Health Media, LLC (AHM), announced the appointment of Ms. Susan Y. Leonard as Chief Compliance Officer. Ms. Leonard will lead the company's initiatives dedicated to understanding and communicating regulatory governance associated with the pharmaceutical, biotechnology and medical device markets.

"Susan's extensive regulatory experience in our industry will further strengthen AHM's current position as a leader in compliance-related services and solutions. She will contribute significantly to our ability to proactively address client's needs as laws change," stated Jeff Brady, President and Chief Executive Officer of AHM.

Ms. Leonard brings with her more than 13 years of legal and regulatory experience in the healthcare and pharmaceutical industry, serving six of those years as in-house regulatory counsel at Schering Plough and Daiichi Sankyo, Inc. She has spent considerable time examining and addressing current aggregate-spend compliance mandates and related state and federal regulations. In addition, she has extensive experience working with the federal Anti- kickback Statute, False Claims Act, Foreign Corrupt Practice Act, HIPAA and the Prescription Drug Marketing Act. Ms. Leonard has led initiatives focused on the evaluation and communication of matters associated with PhRMA Code compliance and adherence to the OIG Guidance on Interactions with Healthcare Professionals.

"Susan's contribution will be significant for the Compliance Solutions division," said Kim Mills, General Manager and Sr. Vice President of AHM's Compliance Solutions. "Her extensive regulatory exposure, as well as her first-hand understanding of our client's needs, will help us help our clients prepare to address current—and pending—legislation regarding promotional spend on healthcare providers."

Prior to serving as in-house counsel, Ms. Leonard was partner at Brach Eichler law firm and associat
'/>"/>

SOURCE Advanced Health Media, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a ... commercialization of prescription ophthalmic pharmaceuticals, announced today that it ... Growth Capital, Inc. (NYSE: HTGC ) (Hercules). ... the Loan and Security Agreement that Alimera,s subsidiary in ... Limited, entered into with Hercules in April of this ...
(Date:9/30/2014)... , Sept. 30, 2014 A study using ... offered a new look at the composition of carotid ... physicians understand and treat the disease, a leading cause ... Baptist Health Lexington between September 2010 and May 2012, ... Journal of the American College of Cardiology (JACC) ...
(Date:9/30/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Bridgewater, New Jersey location received ... Administration (FDA) relating to an inspection in June 2014 ... injectable, which was divested to Galderma S.A. in July ... contract manufacturers (rather than Valeant,s own internal manufacturing) with ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... DIEGO, June 7, 2011 Tocagen Inc. ... high grade glioma, such as those with glioblastoma multiforme ... Toca 511. The multicenter, open-label study is ... of Toca 511 administered intratumorally followed by cycles of ...
... 2011 Topaz Pharmaceuticals Inc., a privately held specialty ... Drug Administration (FDA) accepted for filing the New Drug ... as a treatment for head lice infestations in children ... transition of the Company from the development phase as ...
Cached Medicine Technology:Tocagen's First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma 2Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 2Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 3
(Date:9/30/2014)... Health Day Reporter TUESDAY, ... who are overweight or obese when diagnosed appear to ... weight-related cancer, new research suggests. , , The finding ... only the potential for developing other cancers associated with ... who reported being overweight or obese prior to diagnosis ...
(Date:9/30/2014)... September 30, 2014 Keystone Symposia will convene ... first in its 2014-15 Global Health Series on ... Sheraton Seattle Hotel immediately following the conclusion of ... four-day conference is part of the Keystone Symposia Global ... Foundation, which has also funded travel awards for 36 ...
(Date:9/30/2014)... NJ (PRWEB) September 30, 2014 ... and wellness, is opening another new medical specialty practice ... IMA Cardiology will be located within the ... Ziad Abbud and Dr. Isaac Tawfik of American Heart ... N.J. The new practice will offer Integrated Medicine Alliance ...
(Date:9/30/2014)... been awarded a three-year $1.7 million grant from ... new imaging technologies and data analysis techniques that ... of neurons in the brain interact to process ... the precise interactions between millions of nerve cells ... alterations in these interactions that may be responsible ...
(Date:9/30/2014)... 2014 Elevate , the latest product ... in and out of the gym by providing natural ingredients ... attention of Shane Michaels, prompting an investigative review. , ... reason most people simply just don’t have the ability to ... at work, getting the motivation to finish a project, or ...
Breaking Medicine News(10 mins):Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2
... that some of them are literally ready to dive in ... spa on Saturday opened special baths meant to resemble ramen, ... giant pair of chopsticks overhead and water the aroma of ... have the effects of refreshing your mind, warming your burned-out ...
... Bush seems determined to hang on to his less-and-less-government stance ... veto a bipartisan plan to expand the Childrens Health Insurance ... with the Democratic majority in Congress, with a substantial number ... who want to expand the popular program to cover some ...
... of people reported sick after consuming food at the Chicago ... Cove Persian Cuisine booth at the Taste of Chicago ... July 2. ,Many people were sent to the hospital, ... from salmonella heidelberg bacteria. Tim Hadac, of the Chicago Health ...
... number of doctors in Portugal were refusing to carry out ... the 10th week of pregnancy . ,The law ... at least nine public hospitals out of a total of ... approved the law in March after a February referendum found ...
... southern China, after traders there capitalised on an outbreak of ... press reports ,According to a report Saturday in ... seen arriving late at night and sold to a wild ... ,During the SARS epidemic, which began in southern China in ...
... course at Promises and is officially out of rehab ... the actress has completed her 45-days rehab stint which ... will now be attending an intensive outpatient program. ... completed her 45 days of residential and extended care ...
Cached Medicine News:Health News:President Bush Not for Expansion of Child Health Insurance 2Health News:Food Poisoning at the Chicago Food Festival 2
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Curved shafts. Overall length 3.9 inches....
Delicate curved tying forcep with round handle is excellent for all fine suturing techniques. Useful for corneal transplants where delicate control is required....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Straight 6 mm platform. McPherson handle. Manufactured in titanium. Overall length 3.3 inches....
Medicine Products: